Aspirin-induced apoptosis in Jurkat cells is not mediated by peroxisome proliferator-activated receptor delta

Molecular and Cellular Biochemistry

Volumn 266, Issue 1-2, 2004, Pages 57-63

  López, José M ^a,b   Fernández, Manuel A ^a   Piqué, Maria ^a,b   Gil, Joan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

Apoptosis; Aspirin; Jurkat; Lymphoid cells; NSAIDs; PPAR

Indexed keywords

ACETYLSALICYLIC ACID; CARBACYCLIN; INDOMETACIN; LIGAND; LUCIFERASE; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SULINDAC SULFIDE;

APOPTOSIS; ARTICLE; ASSAY; CELL DEATH; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOID CELL LINE; REPORTER GENE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; JURKAT CELLS; LIGANDS; PPAR ALPHA; PPAR DELTA; PPAR GAMMA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 9444232844     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000049138.67699.7b     Document Type: Article

References (30)

1. Lauer MS: Clinical practice. Aspirin for primary prevention of coronary events. N Engl J Med 346: 1468-1474, 2002
2. Huls G, Koorstra JJ, Kleibeuker, JH: Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362: 230-232, 2003
3. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998
4. Shiff SJ, Rigas B: Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions. Gastroenterology 113: 1992-1998, 1997
5. Tegeder I, Pfeilschifter J, Geisslinger G: Cyclooxygenase-independent actions of cyclooxygenase inhibitors. EASEB J 15: 2057-2072, 2001
6. Chan, TA: Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol 3: 166-174, 2002
7. Castaño E, Dalmau M, Barragán M, Pueyo G, Bartrons R, Gil J: Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells. Br J Cancer 81: 294-299, 1999
8. Bellosillo B, Piqué M, Barragán M, Castaño E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J: Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92: 1406-1414, 1998
9. Piqué M, Barragán M, Dalmau M, Bellosillo B, Pons G, Gil J: Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 480: 193-196, 2000
10. Yamamoto Y, Yin MJ, Lin KM, Gaynor RB: Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem 274: 27307-27314, 1999
11. Liptay S, Bachem M, Hacker G, Adler G, Debatin KM, Schmid RM: Inhibition of nuclear factor kappa B and induction of apoptosis in T-lymphocytes by sulfasalazine. Br J Pharmacol 128: 1361-1369, 1999
12. Stark LA, Din FV, Zwacka RM, Dunlop MG: Aspirin-induced activation of the NF-kappaB signaling pathway: A novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 15: 1273-1275, 2001
13. Spiegelman BM, Flier JS: Adipogenesis and obesity: Rounding out the big picture. Cell 87: 377-389, 1996
14. Van Bilsen M, Van der Vusse GJ, Gilde AJ, Lindhout M, Van der Lee KAJM: Peroxisome proliferator-activated receptors: Lipid binding proteins controlling gene expression. Mol Cell Biochem 239: 131-138, 2002
15. Delerive P, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169: 453-459, 2001
16. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and disease. Nature 405: 421-424, 2000
17. He T-C, Chan TA, Vogelstein B, Kinzler KW: PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345, 1999
18. Gupta RA, Tan J, Krause WE, Geraci MW, Willson TM, Dey SK, DuBois RN: Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer. Proc Natl Acad Sci USA 97: 13275-13280, 2000
19. Tong BJ, Tan J, Tajeda L, Das SK, Chapman JA, DuBois RN, Dey SK: Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma. Neoplasia 2: 483-490, 2000
20. Hatae T, Wada M, Yokoyama C, Shimonishi M, Tanabe T: Prostacyclin-dependent apoptosis mediated by PPAR delta. J Biol Chem 276: 46260-46267, 2001
21. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM: Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91: 7355-7359, 1994
22. Schmidt A, Endo N, Rutledge SJ, Vogel R, Shinar D, Rodan GA: Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids. Mol Endocrinol 6: 1634-1641, 1992
23. Skogsberg J, Kannisto K, Roshani L, Gagne E, Hamsten A, Larsson C, Ehrenborg E: Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. Int J Mol Med 6: 73-81, 2000
24. Kwon G, Hill JR, Corbett JA, McDaniel ML: Effects of aspirin on nitric oxide formation and de novo protein synthesis by RINm5F cells and rat islets. Mol Phamacol 52: 398-405, 1997
25. Iglesias-Serret D, Piqué M, Gil J, Pons G, López JM: Transcriptional and translational control of Mcl-1 during apoptosis. Arch Biochem Biophys 417: 141-152, 2003
26. Mascaró C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D: Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273: 8560-8563, 1998
27. Forman BM, Chen J, Evans RM: Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997
28. Suchanek KM, May FJ, Lee WJ, Holman NA, Roberts-Thomson SJ: Peroxisome proliferator-activated receptor β expression inhuman breast epithelial cell lines of tumorigenic and non-tumorigenic origin. Int J Biochem Cell Biol 34: 1051-1058, 2002
29. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA: Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406-3410, 1997
30. Park BH, Vogelstein B, Kinzler KW: Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells. Proc Natl Acad Sci USA 98: 2598-2603, 2001